Bioavailability of morphine after administration of a new bioadhesive buccal tablet

Biopharmaceutics and Drug Disposition

Volumn 19, Issue 6, 1998, Pages 401-405

  Beyssac, E ^a   Touaref, F ^a   Meyer, M ^b   Jacob, L ^c   Sandouk, P ^d   Aiache, J M ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c Laboratoires Mayoly Spindler   (France)

^d HÔPITAL FERNAND WIDAL   (France)

Author keywords

Bioadhesive tablet; Bioavailability; Buccal route; Morphine

Indexed keywords

MORPHINE;

ADULT; ANALGESIA; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; SUSTAINED RELEASE PREPARATION; TABLET FORMULATION; VOLUNTEER;

ADMINISTRATION, BUCCAL; ADMINISTRATION, ORAL; ADULT; ANALGESICS, OPIOID; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; HUMANS; MORPHINE; TABLETS;

EID: 0031823913     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199809)19:6<401::AID-BDD116>3.0.CO;2-U     Document Type: Article

References (10)

1. D. Bardgett, C. Howard, G.R. Murray, T.N. Calvey and N.E. Williams, Plasma concentrations and bioavailability of a buccal preparations of morphine sulfate. Br. J. Clin. Pharmacol., 17, 198-199 (1984).
2. M. Bell, P. Mishra, B.D. Weldon, G.R. Murray, T.N. Calvey and N.E. Williams, Buccal morphine, a new route for analgesia. Lancet, 1, 71-73 (1985).
3. K.H. Simpson, L.C. Tring and F.R. Ellis, An investigation of premedication with morphine given by the buccal or intramuscular route. Br. J. Clin. Pharmacol., 27, 337-380 (1989).
4. A.P. Fisher, C. Fung and M. Hanna, Serum morphine concentrations after buccal and intramuscular morphine administration. Br.J. Clin. Pharmacol., 24, 685-687 (1987).
5. A.P. Fisher, P. Vine, J. Whitelock and M. Hanna, Buccal morphine premedication. Anaesthesia, 41, 1104-1111 (1986).
6. A.P. Fisher, C. Fung and M. Hanna, Absorption of buccal morphine. A comparison with slow release morphine. Anaesthesia, 39, 587-589 (1988).
7. R. Osborne, S. Joel, D. Trew and M. Slevin, Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of active metabolite morphine-6-glucuronide. Clin. Pharmacol. Ther., 47, 12-19, (1990).
8. US patent no. 5362498.
9. P. Sandouk, A. Serrie, J.M. Scherrman, A. Langlade and J.M. Bourre, Presence of morphine metabolites in human cerebrospinal fluid after intracerebroventricular administration of morphine. Eur. J. Drug Metab. Pharmacokinet., Special issue 111, 166-172 (1991).
10. C.W. Hand, R.A. Moore, H.J. McQuay, M.C. Allen, J.W. Sear, Analysis of morphine and its major metabolites by differential radioimmunoassay. Ann. Clin. Biochem., 24, 153-160 (1987).